Luomalla maksuttoman Inderes-tilin, pääset käsiksi Inderesin analyysiin, voit tilata suositun aamukatsauksen ja seurata sinua kiinnostavia yhtiöitä sekä keskusteluita.
Onko sinulla jo Inderes-tili?
Follow this company like 10711 other investors.
Analyytikko
Redeye has done some adjustments after the Q1 result. Remedy has five ongoing projects which means one of the biggest challenges going forward is to find the best possible personnel to recruit.
Redeye comments on Remedy’s Q1 business review. Revenue was EUR 1.3 million above our estimate, EUR 12.7 million versus EUR 11.4 million. The cost base was roughly in line, which resulted in an EBIT somewhat above our estimate.
Redeye updates its financial projections in Remedy Entertainment. The gaming studio has secured two significant agreements with two of the biggest players in the industry, namely Tencent and Take-Two Interactive.
Redeye comment on Remedy’s full-year report. Remedy posted an EBIT result in line with our estimated and somewhat higher revenue than expected.
Redeye comments on the favorable Tencent agreement and updates its estimates for 2022. A few days before New Year’s Eve Remedy announced the awaited partnership agreement for its upcoming co-operative multiplayer game codenamed Vanguard.
During the night Swedish Time (around 2:00 AM), The Game Awards will be held. This will be a big event for Nordic Gaming. Microsoft will most likely reveal the launch date for Crossfire X.
Redeye comment on the Q3 business review. Remedy reported an undramatic quarter that had a dramatic impact on the stock price, currently down almost 8%. The outlook for the year is unchanged and the business progressed as planned.
Redeye comments on Remedy’s stable H1-report. Revenue amounted to EUR 17.5 million which is above our estimated EUR 15.6 million.
Recently Remedy and the publisher 505 Games (Digital Bros) announced a co-publishing agreement in the universe of Control.
Redeye has made some minor changes in its estimates following the Q1-results in Remedy.